Dudley Robert Michael's Form 4 filing
Transcode Therapeutics, Inc. (RNAZ) · filed Jun 1, 2022
- Accession no.
- 0001104659-22-067099
- Filed
- Jun 1, 2022
- Trade date
- May 27-31, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $55.3K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudley Robert MichaelCIK 0001854161 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2022 | Common Stock | PPurchaseAcquired | +28,000 | $1.84 | +$51,520 | 871,114 | Direct | |
| May 31, 2022 | Common Stock | PPurchaseAcquired | +2,000 | $1.87 | +$3,740 | 873,114 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.